Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/24/2003CA2469435A1 Modulators of lxr
07/24/2003CA2468423A1 Amidoacetonitrile derivatives
07/24/2003CA2464805A1 D-tagatose as an anti-biofilm agent
07/24/2003CA2464131A1 Compositions and methods for controlled release
07/23/2003EP1329507A1 Artificial protein having potentiated immunogenicity of epitope
07/23/2003EP1329457A2 Antipicornaviral compounds, their preparation and use
07/23/2003EP1329456A1 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
07/23/2003EP1329452A1 Medicinal compositions, dose and method for treating malaria
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1329222A1 Isoflavone compositions for use in medicine
07/23/2003EP1329220A1 Cytokine related treatments of disease
07/23/2003EP1329219A1 Apoptosis inducers, caspase cascade activators and anticancer agents
07/23/2003EP1329218A1 Preventives/remedies for portal hypertension
07/23/2003EP1328816A2 Regulation of neutral development by daedalos
07/23/2003EP1328807A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain
07/23/2003EP1328646A2 Regulation of human adenylate cyclase, type iv
07/23/2003EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
07/23/2003EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328620A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells
07/23/2003EP1328552A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof
07/23/2003EP1328550A2 Methods of selecting compounds for modulation of bladder function
07/23/2003EP1328545A1 Human gene critical to fertility
07/23/2003EP1328535A1 Macrolides
07/23/2003EP1328534A2 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance
07/23/2003EP1328528A1 Pharmaceutical compositions
07/23/2003EP1328527A1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
07/23/2003EP1328526A1 3,8-diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
07/23/2003EP1328525A2 2,3,4,5-tetrahydro-1h-[1,4]diazepino[1,7-a]indole compounds
07/23/2003EP1328524A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments
07/23/2003EP1328522A2 Estrogen receptor modulators
07/23/2003EP1328521A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
07/23/2003EP1328519A2 Orally active salts with tyrosine kinase activity
07/23/2003EP1328517A2 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
07/23/2003EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
07/23/2003EP1328515A1 Indoline derivatives and their use as 5-ht2 receptor ligands
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328513A2 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
07/23/2003EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
07/23/2003EP1328511A1 Substituted (e)-styryl benzylsulfones for treating proliferative disorders
07/23/2003EP1328510A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
07/23/2003EP1328509A1 Methods of producing oxazolidinone compounds
07/23/2003EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties
07/23/2003EP1328507A1 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
07/23/2003EP1328506A2 Novel intermediates for use in retinoid synthesis
07/23/2003EP1328504A2 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
07/23/2003EP1328320A2 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
07/23/2003EP1328319A1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases
07/23/2003EP1328314A1 Tumor treatment
07/23/2003EP1328298A1 Methods and compositions for modulating t cell activation and uses thereof
07/23/2003EP1328296A2 Camptothecin conjugates
07/23/2003EP1328294A2 Combination use of acetylcholinesterase inhibitors and gaba-a inverse agonists for the treatment of cognitive disorders
07/23/2003EP1328293A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
07/23/2003EP1328288A2 Protein mixtures for wound healing
07/23/2003EP1328287A1 Compositions and methods for wt1 specific immunotherapy
07/23/2003EP1328282A1 Efficient method for producing compositions enriched in anthocyanins
07/23/2003EP1328281A1 Compositions and methods for treating females sexual response
07/23/2003EP1328280A1 New composition and method for the treatment of dysglucaemia
07/23/2003EP1328279A1 Compositions comprising lignin and methods of making and using the same
07/23/2003EP1328278A1 Analgesic and glucosamine compositions
07/23/2003EP1328277A1 Method for the preparation of a pharmaceutical composition, and its use
07/23/2003EP1328276A1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
07/23/2003EP1328274A1 Compositions containing an inhibitor of dihydrofolate reductase and a folate
07/23/2003EP1328273A2 Felodipine transdermal device and methods
07/23/2003EP1328272A1 Nf-kappa-b inhibitors
07/23/2003EP1328271A2 Method for the treatment of neurological and neuropsychological disorders
07/23/2003EP1328270A2 Method for the treatment of neurological and neuropsychological disorders
07/23/2003EP1328269A2 Association of the cb1 receptor antagonist and a sibutramin for treating obesity
07/23/2003EP1328268A1 Combination of catechin and quercetin for pharmaceutical or dietary use
07/23/2003EP1328267A2 Method of treating cancer using dithiocarbamate derivatives
07/23/2003EP1328266A1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
07/23/2003EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
07/23/2003EP1328264A1 Use of estramustine phosphate in the treatment of bone metastasis
07/23/2003EP1328263A2 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
07/23/2003EP1328261A2 Treatment of neurodegenerative disease
07/23/2003EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides
07/23/2003EP1328259A2 Transdermal therapeutic systems comprising photosensitive active substances
07/23/2003EP1328254A2 Lipid formulations for target delivery
07/23/2003EP1328253A2 Administration of a thiol-based chemoprotectant compound
07/23/2003EP1328252A2 Transdermal pharmaceutical delivery composition
07/23/2003EP1328251A2 Methylphenidate modified release formulations
07/23/2003EP1328236A2 Methods of decreasing or preventing pain using spicamycin derivatives
07/23/2003EP1328186A1 Methods for treating various eye disorders
07/23/2003EP1254134B1 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
07/23/2003EP1251826B1 Diclofenamide suspension gel
07/23/2003EP1242388B1 Method for production of a triazolinethione derivative
07/23/2003EP1235573B1 Combination of riluzole and gabapentin and use thereof for the treatment of motor neuron disorders
07/23/2003EP1228073B1 Imidazole compounds used as phosphodiesterase vii inhibitors
07/23/2003EP1204654B1 Benzofurylpiperazines: 5-ht2c serotonin receptor agonists
07/23/2003EP1189608B1 Levodopa/carbidopa/entacapone pharmaceutical preparation
07/23/2003EP1183028B1 Use of certain macrolide compounds for inducing chondrogenic differentiation
07/23/2003EP1163246B1 Organic-arsenic compounds
07/23/2003EP1150621B1 Composition for preventing surgical adhesions and tissue damage employing fluorinated polymers
07/23/2003EP1148876A4 Calcilytic compounds
07/23/2003EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents
07/23/2003EP1140006B1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
07/23/2003EP1129093B1 Pyrazolopyrimidinone derivatives for the treatment of impotence
07/23/2003EP1128784B1 Therapeutic use of polymers
07/23/2003EP1123106B1 Composition containing eugenol and polyphenols and use of such a composition for wound healing
07/23/2003EP1107741B1 Orally administered controlled drug delivery system providing temporal and spatial control
1 ... 5399 5400 5401 5402 5403 5404 5405 5406 5407 5408 5409 5410 5411 5412 5413 5414 5415 5416 5417 5418 5419 ... 7860